钬激光前列腺剜除术18年经验:单中心研究
该单中心研究回顾了1998年3月至2016年6月由同一专家实施或监督的1476例钬激光前列腺剜除术患者,中位随访9.1年。结果显示I-PSS、生活质量评分、最大尿流率和残余尿量均较术前显著改善,输血率0.8%,尿道狭窄和膀胱颈挛缩发生率分别为1.4%和2.1%,再次手术率1.4%。作者认为该术式安全、有效且持久。
要点
- 中位随访9.1年,I-PSS和生活质量评分较术前显著改善(p<0.001)。
- 在可随访超过10年的132例患者中,最大尿流率和残余尿量显著改善(p<0.001)。
- 输血率0.8%,尿道狭窄1.4%,膀胱颈挛缩2.1%,再次剜除率1.4%。
核心结论
- 钬激光前列腺剜除术在长期随访中是治疗良性前列腺增生安全、有效且持久的手术方式。
研究设计与样本
- 单中心回顾性分析前瞻性收集数据库,纳入1998年3月至2016年6月由同一专家实施或监督的钬激光前列腺剜除术患者1476例,平均年龄70.7岁,中位随访9.1年。
主要发现
- 术后I-PSS和生活质量评分较术前显著改善(15.9±6.5 vs 6.8±5.6和3.1±1.4 vs 1.5±1.4,各p<0.001)。
- 在可随访超过10年的132例患者中,最大尿流率和残余尿量较术前显著改善(平均7.2±4.0 vs 17.7±10.4 ml/s和204±258 vs 43±73 ml,各p<0.001)。
- 前列腺特异性抗原在最近随访时显著降低66.7%(p<0.001)。
- 围手术期输血率为0.8%,术后尿道狭窄21例(1.4%),膀胱颈挛缩30例(2.1%),再次行钬激光前列腺剜除术21例(1.4%)。
- 平均导尿管留置时间和住院时间分别为1.2天和1.3天。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We report our experience with long-term outcomes of holmium laser enucleation of the prostate during a period of 18 years. MATERIALS AND METHODS: We reviewed a prospectively collected database from March 1998 through June 2016 for patients who underwent holmium laser enucleation of the prostate for symptomatic benign prostatic hyperplasia as performed or supervised by a single expert surgeon. Demographic and perioperative data were collected, including scores on the I-PSS (International Prostate Symptom Score), quality of life, peak flow rate, post-void residual urine and prostate specific antigen. Perioperative and late adverse events were also assessed. RESULTS: At a median followup of 9.1 years 1,476 patients with a mean age of 70.7 years were included in study. Mean catheter time and hospital stay were 1.2 and 1.3 days, respectively. Mean ± SD I-PSS and quality of life scores (15.9 ± 6.5 vs 6.8 ± 5.6 and 3.1 ± 1.4 vs 1.5 ± 1.4, respectively, each p <0.001) were significantly improved after holmium laser enucleation of the prostate compared to preoperative values. Likewise the mean peak flow rate and post-void residual urine were significantly improved (mean 7.2 ± 4.0 vs 17.7 ± 10.4 ml per second and 204 ± 258 vs 43 ± 73 ml, respectively, each p <0.001) in the 132 patients who could be followed more than 10 years. Perioperative blood transfusion was required in 0.8% of patients. Prostate specific antigen was significantly reduced by 66.7% at the most recent followup (p <0.001). Postoperative complications included urethral stricture and bladder neck contracture in 21 (1.4%) and 30 patients (2.1%), respectively. Repeat holmium laser enucleation of the prostate was required in 21 patients (1.4%). CONCLUSIONS: Holmium laser enucleation of the prostate is a safe, effective and durable procedure to treat benign prostatic hyperplasia during long-term followup.
引用
- Ibrahim A, Alharbi M, Elhilali MM, et al. 18 Years of Holmium Laser Enucleation of the Prostate: A Single Center Experience. J Urol. 2019. PMID: 31009288. doi:10.1097/JU.0000000000000280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。